(Q42982050)

12 November 2017

title

Hepatitis B and C virus and hepatocellular carcinoma (English)

1 reference

12 November 2017

Olubuyide IO

1

1 reference

12 November 2017

Aliyu B

2

1 reference

12 November 2017

Olalelye OA

3

1 reference

12 November 2017

Ola SO

4

1 reference

12 November 2017

Olawuyi F

5

1 reference

12 November 2017

Malabu UH

6

1 reference

12 November 2017

Odemuyiwa SO

7

1 reference

12 November 2017

Odaibo GN

8

1 reference

12 November 2017

Cook GC

9

1 reference

12 November 2017

publication date

1 January 1997

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

12 November 2017

published in

1 reference

12 November 2017

volume

91

1 reference

12 November 2017

issue

1

1 reference

12 November 2017

page(s)

38-41

1 reference

Important role of hepatitis C virus infection as a cause of chronic liver disease in Somalia

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990387-4

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990387-4

Hepatitis C virus antibody and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990387-4

HCV-associated liver cancer without cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990387-4

A case-control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990387-4

Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990387-4

The prevalence of anti-hepatitis C virus among chinese patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990387-4

Antibodies to hepatitis C virus in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990387-4

Prevalence of hepatitis C virus antibodies in chronic liver disease and hepatocellular carcinoma patients in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990387-4

Prevalence of hepatitis C in tropical communities: the importance of confirmatory assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990387-4

Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990387-4

The leading role of hepatitis B and C viruses as risk factors for the development of hepatocellular carcinoma. A case control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990387-4

10.1016/S0035-9203(97)90387-4

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference